查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1579978

癌症影像系统市场：按产品、成像技术、影像模式、适应症和最终用户 - 2025-2030 年全球预测

Cancer Imaging System Market by Product (Consumables & Accessories, Imaging Systems, Software), Imaging Technology (Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging), Mode of Imaging, Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年癌症影像系统市值为184.3亿美元，预计到2024年将达到201.6亿美元，复合年增长率为9.57%，预计到2030年将达到349.6亿美元。

癌症影像系统市场包括诊断、分期和监测癌症所必需的各种技术，例如 MRI、 电脑断层扫描、PET 扫描、超音波和 X 光成像。全球癌症发病率上升推动了这个市场的需求，这需要先进的诊断工具来改善患者的治疗效果并促进精准医疗。市场的应用遍及各地，包括医院、诊所、诊断实验室和研究机构，主要由肿瘤科医生、放射科医生和医疗专业人员用来规划治疗。成像技术的进步推动了成长，包括整合人工智慧以增强影像分析，从而提高诊断准确性和效率。最新的潜在商机在于为医疗基础设施仍不发达的新兴经济体开发可携式诊断影像设备和个人化应用。然而，法律规范、影像处理系统的高成本以及对辐射暴露的担忧构成了重大挑战。然而，这些问题可以透过投资于最大限度地降低辐射风险并提高成本效益的研究来缓解。该市场受到政府医疗保健计划和癌症治疗资金、高科技公司与医疗保健提供者之间的策略联盟以及消费者对高效医疗保健解决方案日益增长的偏好的显着影响。创新策略包括增强软体以实现更好的影像处理、利用机器学习进行预测分析以及为农村地区开发负担得起的诊断成像设备。随着市场因技术进步而蓬勃发展，持续的研发和策略联盟提供了竞争优势。识别新兴市场中未满足的需求并专注于以患者为中心的影像解决方案可以提供重大的成长机会。从本质上讲，癌症成像系统市场是动态的，创新的机会可以克服其局限性，特别是透过最尖端科技的策略整合和新兴市场的扩张。

主要市场统计
基准年[2023] 184.3亿美元
预测年份 [2024] 201.6亿美元
预测年份 [2030] 349.6亿美元
复合年增长率（%） 9.57%

市场动态：快速发展的癌症成像系统市场的关键市场洞察

供需的动态交互作用正在改变癌症成像系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界老年人口的增加
    • 全球癌症盛行率上升
    • 政府对癌症治疗的支持措施
  • 市场限制因素
    • 癌症影像系统高成本
  • 市场机会
    • 持续合作整合先进成像技术
    • 增加对先进成像技术研发活动的投资
  • 市场挑战
    • 影像资料管理和互通性问题

波特五力：驾驭癌症影像系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解癌症影像系统市场的外部影响

外部宏观环境因素在塑造癌症成像系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解癌症影像系统市场的竞争格局

对癌症成像系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵癌症影像系统市场供应商绩效评估

FPNV 定位矩阵是评估癌症影像系统市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定癌症成像系统市场成功之路的策略分析和建议

对于旨在加强其在全球市场的影响力的公司来说，癌症成像系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球人口老化仍在持续
      • 全球癌症发生率正在上升
      • 政府对癌症治疗的支持措施
    • 抑制因素
      • 癌症影像系统高成本
    • 机会
      • 持续合作整合先进成像技术
      • 增加对先进影像技术研发活动的投资
    • 任务
      • 影像资料管理和互通性问题
  • 市场区隔分析
    • 产品：医院影像系统的使用激增，以满足复杂的影像需求
    • 最终用户：癌症研究机构对先进诊断影像系统的需求不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章癌症影像系统市场：副产品

  • 耗材及配件
  • 影像系统
    • 可携式成像设备
    • 独立影像撷取设备
  • 软体
    • 影像分析软体
    • 辐射资讯系统

第七章癌症影像系统市场影像技术

  • 电脑断层扫描
  • 磁振造影
  • 分子影像
  • 光学成像
  • 正子断层扫描
  • 超音波影像诊断
  • X 光影像

第八章依影像模式分類的癌症影像系统市场

  • 二维成像
  • 3D成像
  • 4D成像

第九章癌症影像系统市场（按适应症）

  • 脑肿瘤
  • 乳癌
  • 子宫颈癌
  • 大肠直肠癌
  • 肝癌
  • 肺癌
  • 摄护腺癌

第 10 章癌症影像系统市场：依最终使用者分类

  • 门诊手术中心
  • 癌症研究组织
  • 影像诊断中心
  • 医院

第十一章美洲癌症影像系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区癌症影像系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的癌症影像系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • GE Healthcare 在 ESTRO 2024 会议上推出人工智慧驱动的个人化肿瘤解决方案
    • GE Healthcare 的 MIM 软体与 Elekta 合作，增强放射治疗并改善病患治疗效果。
    • GE Healthcare 透过收购 MIM Software 扩展癌症成像能力
  • 战略分析和建议

公司名单

  • Agfa-Gevaert NV
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • Curium
  • Elekta AB
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Imaging Endpoints
  • Koning Corporation
  • Medtronic PLC
  • PerkinElmer, Inc.
  • Philips Healthcare
  • Planmed Oy
  • RadNet, Inc.
  • Samsung Medison
  • Siemens Healthineers
  • Spectrum Dynamics Medical
  • Thermo Fisher Scientific Inc.
  • United Imaging Healthcare Co., Ltd.
  • Varian Medical Systems
  • ViewRay, Inc.
  • Ziehm Imaging GmbH
Product Code: MRR-3204321AF6C5

The Cancer Imaging System Market was valued at USD 18.43 billion in 2023, expected to reach USD 20.16 billion in 2024, and is projected to grow at a CAGR of 9.57%, to USD 34.96 billion by 2030.

The cancer imaging system market covers a range of technologies, including MRI, CT scans, PET scans, ultrasound, and X-ray imaging, each essential in diagnosing, staging, and monitoring cancer. This market's necessity stems from the rising global cancer incidence that demands advanced diagnostic tools to improve patient outcomes and facilitate precision medicine. It finds application across hospitals, clinics, diagnostic labs, and research institutions, primarily used by oncologists, radiologists, and medical professionals to guide treatment plans. Growth is spurred by advancements in imaging technology, such as AI integration for enhanced image analysis, which accelerates diagnostic accuracy and efficiency. Latest potential opportunities lie in developing portable imaging devices and personalized applications that cater to emerging economies where healthcare infrastructure is still developing. Meanwhile, regulatory frameworks, high costs of imaging systems, and radiation exposure concerns pose significant challenges. However, investing in research that minimizes radiation risks and enhances cost-effectiveness can mitigate these issues. The market is considerably influenced by governmental healthcare initiatives and funding towards cancer treatment, strategic collaborations between tech companies and healthcare providers, and an increasing consumer preference for efficient healthcare solutions. Innovative strategies include enhancing software for better image processing, utilizing machine learning for predictive analytics, and creating more affordable imaging equipment for rural areas. As the market thrives on technological progression, continuous R&D and strategic alliances can offer competitive advantages. Identifying unmet needs in emerging markets and focusing on patient-centric imaging solutions can provide substantial growth opportunities. In essence, the cancer imaging systems market is dynamic, with opportunities for innovation overshadowing its limitations, particularly through the strategic integration of cutting-edge technologies and expanding reach across developing regions.

KEY MARKET STATISTICS
Base Year [2023] USD 18.43 billion
Estimated Year [2024] USD 20.16 billion
Forecast Year [2030] USD 34.96 billion
CAGR (%) 9.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Imaging System Market

The Cancer Imaging System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population globally
    • Rising prevalence of cancer globally
    • Supportive government initiatives for cancer treatments
  • Market Restraints
    • High costs of cancer imaging systems
  • Market Opportunities
    • Ongoing collaborative activities for integrating advanced imaging technologies
    • Rising investments in R&D activities for advanced imaging technologies
  • Market Challenges
    • Data management and interoperability issues of imaging data

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Imaging System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Imaging System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Imaging System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Imaging System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Imaging System Market

A detailed market share analysis in the Cancer Imaging System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Imaging System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Imaging System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Imaging System Market

A strategic analysis of the Cancer Imaging System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Imaging System Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Bruker Corporation, Canon Medical Systems Corporation, Carestream Health, Curium, Elekta AB, Esaote S.p.A., Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd., Hologic, Inc., iCAD, Inc., Imaging Endpoints, Koning Corporation, Medtronic PLC, PerkinElmer, Inc., Philips Healthcare, Planmed Oy, RadNet, Inc., Samsung Medison, Siemens Healthineers, Spectrum Dynamics Medical, Thermo Fisher Scientific Inc., United Imaging Healthcare Co., Ltd., Varian Medical Systems, ViewRay, Inc., and Ziehm Imaging GmbH.

Market Segmentation & Coverage

This research report categorizes the Cancer Imaging System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables & Accessories, Imaging Systems, and Software. The Imaging Systems is further studied across Portable Imaging Devices and Stand-alone Imaging Equipment. The Software is further studied across Imaging Analysis Software and Radiology Information Systems.
  • Based on Imaging Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging, Optical Imaging, Positron Emission Tomography, Ultrasound Imaging, and X-Ray Imaging.
  • Based on Mode of Imaging, market is studied across 2D Imaging, 3D Imaging, and 4D Imaging.
  • Based on Indication, market is studied across Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, and Prostate Cancer.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Imaging Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population globally
      • 5.1.1.2. Rising prevalence of cancer globally
      • 5.1.1.3. Supportive government initiatives for cancer treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of cancer imaging systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing collaborative activities for integrating advanced imaging technologies
      • 5.1.3.2. Rising investments in R&D activities for advanced imaging technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Data management and interoperability issues of imaging data
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product : Proliferating use of imaging systems in hospitals for intricate imaging needs
    • 5.2.2. End-User : Rising demand for advanced imaging systems cancer research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cancer Imaging System Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Accessories
  • 6.3. Imaging Systems
    • 6.3.1. Portable Imaging Devices
    • 6.3.2. Stand-alone Imaging Equipment
  • 6.4. Software
    • 6.4.1. Imaging Analysis Software
    • 6.4.2. Radiology Information Systems

7. Cancer Imaging System Market, by Imaging Technology

  • 7.1. Introduction
  • 7.2. Computed Tomography
  • 7.3. Magnetic Resonance Imaging
  • 7.4. Molecular Imaging
  • 7.5. Optical Imaging
  • 7.6. Positron Emission Tomography
  • 7.7. Ultrasound Imaging
  • 7.8. X-Ray Imaging

8. Cancer Imaging System Market, by Mode of Imaging

  • 8.1. Introduction
  • 8.2. 2D Imaging
  • 8.3. 3D Imaging
  • 8.4. 4D Imaging

9. Cancer Imaging System Market, by Indication

  • 9.1. Introduction
  • 9.2. Brain Cancer
  • 9.3. Breast Cancer
  • 9.4. Cervical Cancer
  • 9.5. Colorectal Cancer
  • 9.6. Liver Cancer
  • 9.7. Lung Cancer
  • 9.8. Prostate Cancer

10. Cancer Imaging System Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Cancer Research Institutes
  • 10.4. Diagnostic Imaging Centers
  • 10.5. Hospitals

11. Americas Cancer Imaging System Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cancer Imaging System Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cancer Imaging System Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. GE Healthcare unveils AI-enhanced personalized oncology solutions at ESTRO 2024 Congress
    • 14.3.2. GE Healthcare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes
    • 14.3.3. GE Healthcare expands cancer imaging capabilities with acquisition of MIM Software
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agfa-Gevaert N.V.
  • 2. Bruker Corporation
  • 3. Canon Medical Systems Corporation
  • 4. Carestream Health
  • 5. Curium
  • 6. Elekta AB
  • 7. Esaote S.p.A.
  • 8. Fujifilm Holdings Corporation
  • 9. GE Healthcare
  • 10. Hitachi Ltd.
  • 11. Hologic, Inc.
  • 12. iCAD, Inc.
  • 13. Imaging Endpoints
  • 14. Koning Corporation
  • 15. Medtronic PLC
  • 16. PerkinElmer, Inc.
  • 17. Philips Healthcare
  • 18. Planmed Oy
  • 19. RadNet, Inc.
  • 20. Samsung Medison
  • 21. Siemens Healthineers
  • 22. Spectrum Dynamics Medical
  • 23. Thermo Fisher Scientific Inc.
  • 24. United Imaging Healthcare Co., Ltd.
  • 25. Varian Medical Systems
  • 26. ViewRay, Inc.
  • 27. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. CANCER IMAGING SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. CANCER IMAGING SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANCER IMAGING SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANCER IMAGING SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PORTABLE IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY STAND-ALONE IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 333. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 334. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023